Default company panoramic image


Innovative treatment of internal tumours, using electroporation. Currently in clinical trials treating colorectal cancer.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Pilates Dublin . ie, Dublin, Ireland
  • Currency EUR
  • Founded October 2011
  • Employees 2
  • Website

Company Summary

MitaMed has commenced clinical trials for its ground breaking treatment for gastrointestinal and lung cancers. Current Standards of Care have low success rates, severe impact on Quality of Life and are expensive. MitaMed’s solution addresses these shortcomings. Over 1.3MM people are diagnosed with colorectal, oesophageal or lung cancer in EU/US per year and would benefit from our minimally invasive, out-patient treatment, with lower side effects.


  • Default avatar
    Michael Loftus

    Michael is CEO and co-founder of MitaMed. He spent over 20 years working with the Medical Device Company BD. As GM in Ireland, responsibilities included strategic, financial and operational ownership, with an €80 MM annual budget and a €100 MM capital investment programme to reposition its activities to reflect the changing environment. He gained international experience with site operations responsibilities for five years in the US.

  • Default avatar
    Declan Soden

    Declan is CTO and co-founder of MitaMed. He is General Manager of the Cork Cancer Research Centre (CCRC), with responsibilities for strategic planning, fundraising and coordinating clinical trial activities. He has a PhD in molecular biology and over 10 years of experience in the field of cancer research and medical device R&D. His research interests is in minimally invasive technologies and the development of immuno-therapy for cancer.


  • Default avatar
    William Fry
    Default avatar
    RTW Chartered Acclountants